Real-time enrollment status for this large b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 3:48 PM UTC
| NCT Number | NCT05852717 |
| Recruiting Status | Recruiting |
| Condition | Large B-cell Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 35 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Dipenkumar Modi |
| Last Updated on CT.gov | July 10, 2026 (1 week ago) |
As of July 17, 2026: Clinical trial NCT05852717 is currently recruiting participants. This phase2 study for large b-cell lymphoma is actively seeking new participants at 4 locations across the United States. The study is sponsored by Dipenkumar Modi. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05852717 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05852717 was last updated 1 week ago (July 10, 2026). HelloStudys verifies this status automatically.